Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2024-09-04 00:00:00 ET · period of report 2024-09-01 · accession 0001062993-24-016173 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-04 | 2024-09-01+ | BIO | BARRY JAMES | EVP, Pres, LSG | F - Tax | $336.72 | -389 | 460.56 | -46% | -$131.0K |
| D | 2024-09-04 | 2024-09-04 | BIO | BARRY JAMES | EVP, Pres, LSG | S - Sale+OE | $330.49 | -623 | 146.56 | -81% | -$205.9K |
| DM | 2024-09-04 | 2024-09-01+ | BIO | BARRY JAMES | EVP, Pres, LSG | M - OptEx | $0.00 | +1,082 | 524.56 | New | $0 |
| DM | 2024-09-04 | 2024-09-01+ | BIO | BARRY JAMES | EVP, Pres, LSG | M - OptEx | $0.00 | -1,082 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2024-09-03 | F | D | 78 | $334.31 | 769.56 | D | — | — | |
| 2 | Common | Bio-Rad A Common Stock | 2024-09-04 | S | D | 623 | $330.49 | 146.56 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $330.40 to $330.63, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Bio-Rad A Common Stock | 2024-09-01 | M | A | 250 | $0.00 | 326.56 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. (F2) Includes 45.6820 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2024. |
| 4 | Common | Bio-Rad A Common Stock | 2024-09-01 | F | D | 90 | $337.32 | 236.56 | D | — | — | |
| 5 | Common | Bio-Rad A Common Stock | 2024-09-01 | M | A | 173 | $0.00 | 409.56 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 6 | Common | Bio-Rad A Common Stock | 2024-09-01 | F | D | 62 | $337.32 | 347.56 | D | — | — | |
| 7 | Common | Bio-Rad A Common Stock | 2024-09-03 | M | A | 217 | $0.00 | 847.56 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 8 | Common | Bio-Rad A Common Stock | 2024-09-02 | F | D | 95 | $337.32 | 630.56 | D | — | — | |
| 9 | Common | Bio-Rad A Common Stock | 2024-09-02 | M | A | 265 | $0.00 | 725.56 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 10 | Common | Bio-Rad A Common Stock | 2024-09-01 | M | A | 177 | $0.00 | 524.56 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 11 | Common | Bio-Rad A Common Stock | 2024-09-01 | F | D | 64 | $337.32 | 460.56 | D | — | — | |
| 12 | Derivative | Restricted Stock Units | 2024-09-01 | M | D | 177 | $0.00 | 178 | D | $0.00 · — to — | 177 Bio-Rad A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F7) On September 1, 2021, the reporting person was granted 709 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 13 | Derivative | Restricted Stock Units | 2024-09-03 | M | D | 217 | $0.00 | 0 | D | $0.00 · — to — | 217 Bio-Rad A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F9) On September 3, 2019, the reporting person was granted 1,083 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |
| 14 | Derivative | Restricted Stock Units | 2024-09-01 | M | D | 173 | $0.00 | 348 | D | $0.00 · — to — | 173 Bio-Rad A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F6) On September 1, 2022, the reporting person was granted 694 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 15 | Derivative | Restricted Stock Units | 2024-09-01 | M | D | 250 | $0.00 | 752 | D | $0.00 · — to — | 250 Bio-Rad A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F5) On September 1, 2023, the reporting person was granted 1,002 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 16 | Derivative | Restricted Stock Units | 2024-09-02 | M | D | 265 | $0.00 | 0 | D | $0.00 · — to — | 265 Bio-Rad A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F8) On September 2, 2020, the reporting person was granted 1,059 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |